PBCG Partners with Greater Gift
Event organizer will implement charitable giving through non-profit’s vaccine donation program.
Pharmaceutical Business Conference Group (PBCG), a clinical trials conference organizer, will partner with Greater Gift, a non-profit with the mission to increase awareness of clinical research as a care option, to implement charitable giving programs at its Clinical Outsourcing Group meetings, which are held globally throughout the year.
"We are thrilled to partner with Pharmaceutical Business Conference Group to further our mission and simplify the process for corporations and individuals to contribute to pay forward the gift of health," said Joan Chambers, CEO of Greater Gift, in a release. She added, "PBCG events attract top leaders in the pharmaceutical space, establishing their conferences as an ideal platform for increasing charitable contributions from this community."
The program will utilize Greater Gift’s collaboration with GAVI, the Vaccine Alliance. PBCG outsourcing speakers will use a referral code for pharmaceutical and biotech colleagues to register, triggering a PBCG donation. The charity, with GAVI, then donates a vaccine to a child in need. Registrants receive notification post-event as to how many donations their contributions made.
The new charitable referral program debuts at PBCG's Clinical Outsourcing Group Europe meeting on October 10 and 11 in Milan, Italy.
Reference: “Pharmaceutical Business Conference Group Partners with Greater Gift to Expand Vaccine Donation Programme,”London, United Kingdom, August 23, 2023.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
